Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|April 12, 2019
Improvements in Lung Function with Nebulized Revefenacin in the Treatment of Patients with Moderate to Very Severe COPD: Results from Two Replicate Phase III Clinical TrialsGary T Ferguson, Gregory Feldman, Krishna K Pudi, et al.
Antioxidants & Redox Signaling|September 12, 2008
Role of Nox4 and Nox2 in hyperoxia-induced reactive oxygen species generation and migration of human lung endothelial cellsSrikanth Pendyala, Irina A Gorshkova, Peter V Usatyuk, et al.
Respiratory Research|November 1, 2019
Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive Pulmonary Disease (COPD)James F Donohue, Edward Kerwin, Sanjay Sethi, et al.
The Journal of Experimental Medicine|June 29, 2011
FoxM1 mediates the progenitor function of type II epithelial cells in repairing alveolar injury induced by Pseudomonas aeruginosaYuru Liu, Ruxana T Sadikot, Guy R Adami, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 26, 2016
Hyperoxia-induced p47phox activation and ROS generation is mediated through S1P transporter Spns2, and S1P/S1P1&2 signaling axis in lung endotheliumAnantha Harijith, Srikanth Pendyala, David L Ebenezer, et al.
Circulation Research|February 22, 2003
Oxygen sensing by primary cardiac fibroblasts: a key role of p21(Waf1/Cip1/Sdi1)Sashwati Roy, Savita Khanna, Alice A Bickerstaff, et al.
Pageof 3